Premium
Hispidulin: A novel natural compound with therapeutic potential against human cancers
Author(s) -
Ashaq Aisha,
Maqbool Muhammad F.,
Maryam Amara,
Khan Muhammad,
Shakir Hafiz A.,
Irfan Muhammad,
Qazi Javed I.,
Li Yongming,
Ma Tonghui
Publication year - 2021
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.6862
Subject(s) - cancer , medicine , drug discovery , metastasis , angiogenesis , pharmacology , anticancer drug , drug , cancer research , bioinformatics , biology
Cancer is one of the most devastating disease and leading cause of death worldwide. The conventional anticancer drugs are monotarget, toxic, expensive and suffer from drug resistance. Development of multi‐targeted drugs from natural products has emerged as a new paradigm to overcome aforementioned conventionally encountered obstacles. Hispidulin (HIS), is a biologically active natural flavone with versatile biological and pharmacological activities. The anticancer, antimutagenic, antioxidative and anti‐inflammatory properties of HIS have been reported. The aim of this review is to summarize the findings of several studies over the last few decades on the anticancer activity of HIS published in various databases including PubMed, Google Scholar, and Scopus. HIS has been shown to reduce the growth of cancer cells by inducing apoptosis, arresting cell cycle, inhibiting angiogenesis, invasion and metastasis via modulating multiple signaling pathways implicated in cancer initiation and progression. Multitargeted anticancer activity of HIS remains the strongest point for developing it into potential anticancer drug. We also highlighted the natural sources, anticancer mechanism, cellular targets, and chemo‐sensitizing potential of HIS. This review will provide bases for design and conduct of further pre‐clinical and clinical trials to develop HIS into a lead structure for future anticancer therapy.